Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A. Palmu(Finnish Institute for Health and Welfare), Jukka Jokinen(Finnish Institute for Health and Welfare), Dorota Borys(GlaxoSmithKline (Belgium)), Heta Nieminen(Finnish Institute for Health and Welfare), Esa Ruokokoski(Finnish Institute for Health and Welfare), Lotta Siira(Finnish Institute for Health and Welfare), Taneli Puumalainen(Glaxosmithkline (Finland)), Patricia Lommel(GlaxoSmithKline (Belgium)), Marjan Hezareh(GlaxoSmithKline (Belgium)), Marta Moreira(GlaxoSmithKline (Belgium)), Lode Schuerman(GlaxoSmithKline (Belgium)), Terhi Kilpi(Finnish Institute for Health and Welfare)
Cited by 225
Abstract
Related Papers
No related papers found
Powered by citation graph analysis